CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
FGFR3-TACC3: A novel gene fusion in malignant melanoma
Jiyun Lee, Jeeyun Lee, Sang Duk Hong, Kee-Taek Jang, Su Jin Lee
Precis Future Med. 2018;2(2):71-75.   Published online June 20, 2018

Excel Download

FGFR3-TACC3: A novel gene fusion in malignant melanoma
Precision and Future Medicine. 2018;2(2):71-75   Crossref logo
Link1 Link2 Link3

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
Acta Neuropathologica Communications. 2019;7(1):   Crossref logo
Link1 Link2 Link3

FGFR3–TACC3: A novel gene fusion in cervical cancer
Gynecologic Oncology Reports. 2015;13:53-56   Crossref logo
Link1 Link2

Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16·3;q32) in multiple myeloma
British Journal of Haematology. 2004;126(1):72-76   Crossref logo
Link1 Link2 Link3

FGFR3–TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
Open Biology. 2017;7(8):170080   Crossref logo
Link1 Link2 Link3

Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer
Precision and Future Medicine. 2017;1(4):168-172   Crossref logo
Link1 Link2 Link3

A novel DPP10 (intergenic)-NTRK3 fusion in a patient with facial malignant melanoma and potentially benefit from NTRK inhibitors
Oral Oncology. 2021;105288   Crossref logo
Link1 Link2

OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion
Neuro-Oncology. 2019;21(Supplement_3):iii18-iii19   Crossref logo

Genomic Profiling of Circulating Tumor DNA in Relapsed EGFR -mutated Lung Adenocarcinoma Reveals an Acquired FGFR3 - TACC3 Fusion
Clinical Lung Cancer. 2017;18(3):e219-e222   Crossref logo
Link1 Link2

Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3 ‐ TACC3 Fusion and Recurrent Glioblastoma
The Oncologist. 2020;26(3):173-177   Crossref logo
Link1 Link2 Link3